Prescription drug · BLA
Papzimeos (zopapogene imadenovec) NDC 84768-511
Zopapogene imadenovec 500000000000 {VP}/mL · Injection, Suspension · Subcutaneous · Precigen, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 84768-511-01 | 84768051101 | 1 POUCH in 1 CARTON (84768-511-01) / 1 VIAL in 1 POUCH / 1 mL in 1 VIALMarketed from Sep 15, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Papzimeos
- Generic name (nonproprietary)
- zopapogene imadenovec
- Active ingredients
- Zopapogene imadenovec — 500000000000 {VP}/mL
- Dosage form
- Injection, Suspension
- Route
- Subcutaneous
- Labeler
- Precigen, Inc.
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125832
- Marketing start
- Listing expires
- Identifiers
- Product ID 84768-511_f1d461da-c962-444c-898a-c0c0aaca9fafSPL ID f1d461da-c962-444c-898a-c0c0aaca9fafSPL set ID 103db7f1-8540-4bea-935e-217d69e7aa01RxCUI 2723367, 2723374UNII C525BYS7TP
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N484768051101followed by a unit qualifier and the quantityPackage 84768-0511-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
PAPZIMEOS is indicated for the treatment of adults with recurrent respiratory papillomatosis. PAPZIMEOS™ is a non-replicating adenoviral vector-based immunotherapy indicated for the treatment of adults with recurrent respiratory papillomatosis. ( 1 )
Excerpt only. Read the full label for complete information.